Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results
Date:3/8/2011

nts in and advance to affiliated companies

121,865

121,220

18,366Other assets

44,502

41,234

6,248Totalassets3,137,9023,218,252487,614LiabilitiesCurrent liabilitiesShort-term borrowings and current portion of long-term debts

76,000

360,000

54,545Accounts payable

41,439

49,638

7,521Bills payable

110,810

-

-Other payables and accrued liabilities

464,616

596,208

90,335Totalcurrentliabilities692,8651,005,846152,401Long-term debts, excluding current portion

122,685

19,306

2,925Deferred tax liabilities

93,108

68,811

10,426Other liabilities

21,561

22,593

3,423Totalliabilities930,2191,116,556169,175Redeemable noncontrolling interest-47,4537,190Shareholders' equitySimcere shareholders' equity Ordinary shares at par

8,716

8,422

1,276Additional paid-in capital

1,170,687

890,950

134,992Accumulated other comprehensive loss

(43,886)

(31,972)

(4,844)Retained earnings

846,707

1,011,272

153,223Total equity attributable to Simcere 1,982,2241,878,672284,647Noncontrolling interest

225,459

175,571

26,602Total shareholders' equity2,207,6832,054,243311,249Commitments and contingenciesTotalliabilities, redeemable noncontrolling interest and shareholders'equity3,137,9023,218,252487,614Note: The conversions of Renminbi (RMB) into United States dollars (USD) as at the reporting dates are based on the noon buying rate of USD1.00 = RMB6.600 on December 31, 2010 as set forth in the H. 10 statistical release of the Federal Reserve Board. No representation is intended to imply that the RMB amounts could have been, or could be, converted, realized or settled into U.S. dollars at that rate on the reporting dates.<
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2010 Unaudited Financial Results on Tuesday, March 8, 2011
2. Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
3. Simcere Pharmaceutical Group Announces Resignation of CFO Frank Zhao
4. Simcere Pharmaceutical Group to Announce Third Quarter 2010 Financial Results on Thursday, November 11, 2010
5. Simcere Pharmaceutical Group to Announce Second Quarter 2010 Financial Results on Thursday, August 12, 2010
6. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
7. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
8. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
9. Simceres Diosmectite API Passes EU-GMP Inspection
10. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
11. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... BIRMINGHAM, Ala. , Jan. 23, 2015 Gem ... (STS) patients have been enrolled into the Company,s Phase ... efficacy and safety of Gem,s lead compound, GPX-150 (an ... for advanced or metastatic disease. Logo - ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... 12, 2011 Mylan Inc. (Nasdaq: MYL ... president of Dey Pharma, L.P., Mylan,s fully integrated specialty ... 20 years of professional experience in strategic product launches, ... he served as president and chief executive officer of ...
... Inc. (NYSE Amex: INO ), which is advancing ... that Dr. J. Joseph Kim, President and CEO, will present ... Healthcare Conference taking place December 13-14 at the Waldorf-Astoria in ... 13 10:50 am ET A live and archived ...
Cached Medicine Technology:Mylan Names John Thievon President of Dey Pharma 2Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference 2Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference 3
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and ... relationship in an effort to further promote visibility and adoption ... has long made AMA journals available via its subscription services, ... JAMA Network. , Long known as both a ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... are invited to attend and cover the 2008 ... be held March 16-19, 2008, at the Hyatt ... organized by the Centers for Disease Control and ... Council of State and Territorial Epidemiologists, the Association ...
... It seems to plug calcium leaks that cause tiring ... News) -- An experimental drug may help fatigued athletes ... say physiologists at Columbia University Medical Center. , Tests ... regimens, tiny leaks of calcium continuously enter the muscle ...
... Johns Hopkins researchers from the Whiting School of Engineering and the ... on a chip - designed to mimic the chemical complexities of ... cells in the brain work together to form the nervous system. ... story in the February 2008 issue of the British journal Lab ...
... Tribune has published a,feature story on the terrible incidence ... loving dog owners, and treatments and scientific,research under way ... of release.,Morris Animal Foundation (MAF) is cited as leading ... 10 to 20 years. MAF can help provide the,press ...
... (WASHINGTON, February 12, 2008) A new study demonstrates for ... to create functional immune system blood cells, a finding which ... cells as an alternative source of cells for bone marrow ... and immune disorders, who need these transplants for treatment, was ...
... VEGAS, Feb. 12 For years, celebrities and,socialites ... products, including,toothpaste. Now, however, U.S. suburbanites and urban ... local drugstore to enjoy luxurious French oral,care., ... toothpaste in France for more than three,decades, has ...
Cached Medicine News:Health News:2008 International Conference on Emerging Infectious Diseases 2Health News:Muscle Fatigue Drug May Fight Heart Failure 2Health News:'Lab on a chip' mimics brain chemistry 2Health News:A functional immune system can be derived from embryonic stem cells, preliminary study finds 2Health News:A functional immune system can be derived from embryonic stem cells, preliminary study finds 3Health News:A Favorite in France, Elgydium(R) Toothpaste Makes Entrance Into the U.S. Market 2
ARION is a long-pulsed alexandrite laser system with a wavelength of 755 nm...
Used for cystometry and urethral pressure profilometry. A loop is employed to enhance catheter retention and stabilization within the bladder. Supplied sterile in peel-open packages. Intended for one...
... Compact desktop analyzer for fast point-of-care ... syndrome, deep vein thrombosis and/or pulmonary embolism. ... rooms. , ,When every minute counts, ... determination of troponin T, myoglobin, and D-Dimer ...
... Collection Tubes are 100% plastic capillary blood ... of applications, the Capillary Collection Tubes are ... and a micro tube.,The capillary tube uses ... the micro tube thereby eliminating the tendency ...
Medicine Products: